Searched for
FRENCH DRUGMAKER SANOFI
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employeesFrench drugmaker Sanofi is set to significantly expand its global capability centre in Hyderabad. The company plans to more than double its...
- Sanofi to build $1 billion insulin production base in ChinaSanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...
- Sanofi in exclusive talks with CD&R over sale of $17 bn OpellaFrench pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella to U.S. private...
- Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...
- Sanofi looking to expand India hub with Rs 3.6k-cr pushThe Hyderabad GCC will support Sanofi's global operations spanning commercial, manufacturing, supply chain research and development (R&D) a...
- Sanofi gets nod for injectable Polio vaccineThe announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a...
- Sanofi plans to split consumer health unit to narrow focusSanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...
- Sanofi reinvigorates India business, with eye on higher growthThe company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovati...
- Sanofi to let go of staff at vaccine plants in India as part of reviewThe drugmaker is offering voluntary retirement scheme (VRS) to all its employees at two sites near Hyderabad, a spokesperson for Sanofi's I...
- Sanofi launches global health brand, to offer 30 meds on non-profit basisThe treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the ...
- GSK, Sanofi to make 200 mn doses available for COVID-19 vaccine allianceCOVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan. The Unit...
- Sanofi and GSK launch trial for COVID-19 protein-based vaccineSanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which th...
- US court rules against Sun Pharma over cancer drugFrench drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun Pharmaceuticals over Eloxatin.
- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in IndiaAccording to a person close to the deal, Sanofi-Aventis may buy a majority stake or key brands valuing the Indian company at around Rs 450 ...
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Genzyme board rejects Sanofi $69-a-share offerBiotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...
Load More
